Nestlé to buy Pfizer’s infant-nutrition business

Swiss food and drink giant Nestlé has announced a deal to acquire Pfizer’s infant-nutrition business for $11.85 billion (SFr10.8 billion).

This content was published on April 23, 2012 - 09:26 and agencies

The Vevey-based company says the acquisition, subject to regulatory approval, would “enhance its position in global infant nutrition”.

Nestlé CEO Paul Bulcke called the deal to buy the Pfizer nutrition unit “an excellent strategic fit”.

Nestlé said in a statement on Monday that estimated sales from the acquired business would be $2.4 billion in 2012.

It said 85 per cent of those sales are in emerging markets, many of which have large, fast-growing populations.

Nestlé is one of the world’s largest sellers of infant formula and may face some antitrust hurdles to complete the deal.

This article was automatically imported from our old content management system. If you see any display errors, please let us know:

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?